SCHEMBL1327345

SCHEMBL1327345

CN(C)C(c1cccc(F)c1)C1CCC(CNC(=O)c2ccccc2Br)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
NPY2R P49146 1/20 0.40
POLB P06746 1/20 0.39
CHRM1 P11229 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAN2A1 Q16706 1/20 0.38
MAN1B1 Q9UKM7 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
OPRM1 P35372 2/20 0.38
KCNK3 O14649 1/20 0.37
PTGIR P43119 1/20 0.37
TACR3 P29371 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
AR P10275 1/20 0.37
CHRM2 P08172 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2308504 0.91 OPRL1 (0.40) OPRL1NPY2RCHRM1CYP1A2CYP3A4
SCHEMBL1326706 0.89 HTR7 (0.42) OPRL1CHRM1NPC1RAB9AOPRM1
SCHEMBL28774679 0.89 NPC1 (0.48) OPRL1CHRM1NPC1RAB9AALDH1A1
SCHEMBL1327843 0.87 LMNA (0.45) OPRL1SMN1; SMN2NPC1RAB9AOPRM1
SCHEMBL1326568 0.83 SMN1; SMN2 (0.42) SMN1; SMN2POLBCHRM1NPC1RAB9A
SCHEMBL1327463 0.83 OPRL1 (0.40) OPRL1CHRM1NPC1RAB9ACYP1A2
SCHEMBL493392 0.83 OPRL1 (0.44) OPRL1OPRM1PTGIR
SCHEMBL2310616 0.82 CACNA1I (0.48) OPRL1OPRM1
SCHEMBL1326746 0.81 NPC1 (0.46) CHRM1NPC1RAB9AKCNK3PTGIR
SCHEMBL492704 0.81 OPRL1 (0.44) OPRL1OPRM1PTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US claimed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP claimed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US claimed
CN-101384544-A Substituted cyclohexylmethyl derivatives GRUENENTHAL GMBH (DE) 2009-03-11 CN claimed
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US disclosed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP disclosed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US disclosed
CN-101384544-A Substituted cyclohexylmethyl derivatives GRUENENTHAL GMBH (DE) 2009-03-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds CNR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C1R OPRL1 238/4885SMN1; SMN2 1867/4885NPY2R 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.